TY - JOUR
KW - Adjuvants, Immunologic
KW - Animals
KW - Antibody-Producing Cells
KW - Dose-Response Relationship, Drug
KW - Drug Evaluation, Preclinical
KW - Female
KW - Immunity, Cellular
KW - Leprostatic Agents
KW - leprosy
KW - Lethal Dose 50
KW - Male
KW - Mice
KW - Mice, Inbred C57BL
KW - Mice, Inbred CBA
AU - Goloshchapova E N
AB - <p>Antimycobacterial and immunotropic characteristics of new antileprosy drugs, made in this country, have been studied and compared with those of dapsone. Animal experiments have demonstrated a high immunostimulating activity of the new drugs; this calls for clinical trials of these agents, for they may improve the therapy efficacy, help prevent the disease recurrences, and cut down the length of treatment for leprosy.</p>
BT - Vestnik dermatologii i venerologii
C1 - http://www.ncbi.nlm.nih.gov/pubmed/2773589?dopt=Abstract
DA - 1989
IS - 5
J2 - Vestn Dermatol Venerol
LA - rus
N2 - <p>Antimycobacterial and immunotropic characteristics of new antileprosy drugs, made in this country, have been studied and compared with those of dapsone. Animal experiments have demonstrated a high immunostimulating activity of the new drugs; this calls for clinical trials of these agents, for they may improve the therapy efficacy, help prevent the disease recurrences, and cut down the length of treatment for leprosy.</p>
PY - 1989
SP - 7
EP - 9
T2 - Vestnik dermatologii i venerologii
TI - [Immunocorrective properties of new antileprotic preparations].
SN - 0042-4609
ER -